-+ 0.00%
-+ 0.00%
-+ 0.00%

*Protara Therapeutics Plans to Use Net Proceeds From Offering to Fund Clinical Development of TARA-002, Develop Other Clinical Programs >TARA

Dow Jones·12/05/2025 03:09:00

Please log in to view news